| |
| |
|
| Insider
Information: |
El Coronado Holdings, Llc |
| Relationship: |
10% Owner |
| City: |
Pearce |
| State: |
AZ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
6,674,725 |
|
|
Indirect Shares
|
27,131,085 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$11,304,639 |
|
|
| Total
Shares |
33,805,810 |
|
|
| Total
Value |
$11,304,639 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nmi Health Inc |
NANM |
10% Owner |
2005-03-02 |
0 |
2009-06-22 |
9,805,857 |
Premium* |
|
|
Novogen Limited (ADR) |
NVGN |
10% Owner |
2006-04-21 |
0 |
2013-11-05 |
385,749 |
Premium* |
|
|
Chelsea Therapeutics Internation... |
CHTP |
10% Owner |
2007-03-22 |
0 |
2012-12-17 |
6,432,673 |
Premium* |
|
|
MEI Pharma Inc |
MEIP |
10% Owner |
2012-12-03 |
0 |
2012-12-03 |
3,832,081 |
Premium* |
|
|
Protea Biosciences Group Inc |
PRGB |
10% Owner |
2013-12-30 |
6,674,725 |
2013-12-30 |
6,674,725 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
289 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-16 |
4 |
B |
$5.08 |
$67,590 |
I/I |
13,100 |
2,788,897 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-16 |
4 |
B |
$9.56 |
$132,691 |
I/I |
13,875 |
2,362,115 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-17 |
4 |
B |
$5.33 |
$71,357 |
I/I |
13,300 |
2,802,197 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-17 |
4 |
B |
$9.47 |
$47,330 |
I/I |
5,000 |
2,367,115 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-18 |
4 |
B |
$5.40 |
$9,374 |
I/I |
1,736 |
2,803,933 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-21 |
4 |
B |
$9.27 |
$74,178 |
I/I |
8,000 |
2,375,115 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-21 |
4 |
B |
$5.40 |
$65,880 |
I/I |
12,200 |
2,816,133 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-22 |
4 |
B |
$5.29 |
$160,844 |
I/I |
30,113 |
2,846,246 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-23 |
4 |
B |
$5.29 |
$16 |
I/I |
3 |
2,846,249 |
1.42 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-23 |
4 |
B |
$9.49 |
$49,322 |
I/I |
5,200 |
2,380,315 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-24 |
4 |
B |
$5.20 |
$103,720 |
I/I |
19,512 |
2,865,761 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-24 |
4 |
B |
$9.11 |
$91,100 |
I/I |
10,000 |
2,390,315 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-25 |
4 |
B |
$5.29 |
$51,994 |
I/I |
9,825 |
2,875,586 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-25 |
4 |
B |
$9.11 |
$65,578 |
I/I |
7,200 |
2,397,515 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-29 |
4 |
B |
$5.38 |
$53,800 |
I/I |
10,000 |
2,885,586 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-29 |
4 |
B |
$9.02 |
$17,138 |
I/I |
1,900 |
2,399,415 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-30 |
4 |
B |
$5.19 |
$90,753 |
I/I |
17,500 |
2,903,086 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-05-30 |
4 |
B |
$9.23 |
$92,256 |
I/I |
10,000 |
2,409,415 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-05-31 |
4 |
B |
$5.18 |
$102,668 |
I/I |
19,830 |
2,922,916 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-01 |
4 |
B |
$5.25 |
$45,674 |
I/I |
8,700 |
2,931,616 |
1.5 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-01 |
4 |
B |
$9.63 |
$74,119 |
I/I |
7,700 |
2,417,115 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-04 |
4 |
B |
$5.27 |
$77,087 |
I/I |
14,640 |
2,946,256 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-05 |
4 |
B |
$5.29 |
$52,862 |
I/I |
10,000 |
2,956,256 |
1.5 |
- |
|
| CHTP |
Chelsea Therapeutics Inte... |
10% Owner |
– – • |
2007-06-06 |
4 |
B |
$5.08 |
$2,540 |
I/I |
500 |
2,956,756 |
1.42 |
- |
|
| NVGN |
Novogen Limited (ADR) |
10% Owner |
– – • |
2007-06-06 |
4 |
B |
$9.14 |
$81,672 |
I/I |
8,940 |
2,426,055 |
1.5 |
- |
|
289 Records found
|
|
Page 5 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
